ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

INDV Indivior Plc

931.00
-19.00 (-2.00%)
17 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BN4HT335 ORD USD0.50
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -19.00 -2.00% 931.00 935.00 937.50 953.50 906.50 938.00 325,897 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1.09B 2M 0.0154 607.79 1.23B
Indivior Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker INDV. The last closing price for Indivior was 950p. Over the last year, Indivior shares have traded in a share price range of 555.00p to 1,770.00p.

Indivior currently has 129,575,205 shares in issue. The market capitalisation of Indivior is £1.23 billion. Indivior has a price to earnings ratio (PE ratio) of 607.79.

Indivior Share Discussion Threads

Showing 4226 to 4244 of 4800 messages
Chat Pages: Latest  180  179  178  177  176  175  174  173  172  171  170  169  Older
DateSubjectAuthorDiscuss
05/6/2023
08:01
Underlying EPS was $0.41 in Q1, annualised this is EPS of £1.32 and puts these shares on a forward PE of just 12x... With sublocade growth averaging 12.5% a quarter over the last 6 quarters this looks far too cheap. Suspect it rerates to between 15-20x FY23 PE once on NASDAQ (£20-26)
74tom
05/6/2023
07:25
Good start! Now let’s build from there please
youngers
05/6/2023
06:36
Hoping for a pop here this morning 🙏
youngers
04/6/2023
21:32
I'm sure that Indivior bust a gut to get a settlement over the line before the Nasdaq listing.You have to factor in that these sort of legal proceedings are endemic when it comes to holding a company like Indivior.Even Glaxo recently got cited in respect of Zantac,the drug that transformed the group back in the 1980s.There's always going to be some legal johnny,rightly or wrongly, in the wings looking to the main chance with these drug companies.It's a question of evaluating whether the ever present threat of litigation is discounted when assessing the company's trading prospects.Fairly impossible task unless you're clairvoyant!Every litigation episode takes a bit of bounce out of the bungee i suppose.So,i don't think a race back to £20 is likely short term but maybe high teens is possible if the US listing gets off to a good start.
steeplejack
03/6/2023
09:35
Mm 42 plus US States might well require an awful lot of lawyers even to cover the field but the deal is done and for once well within estimates -so where’s the beef! Will see how the share price progresses now especially with the12June added listing
gregmorg
02/6/2023
18:32
Interesting that a 100m settlement is in line with a 290m provision. That’s some bloody legal bill!!

Only ones who ever wins are the lawyers

youngers
02/6/2023
18:13
Brilliant news!! Back to £20 next week?
youngers
02/6/2023
17:24
Great news tonight (I think).
dealy
30/5/2023
08:29
Perhaps on our demise (hopefully not before)some of the more active private investors will be stuffed and exhibited in a museum.I will keep a wary eye out for roaming taxidermists.
steeplejack
27/5/2023
11:34
I would say the death of the retail stock picker / investor is pretty much universal. Hardly anyone i know across many countries would even consider buying a single share (other than the uber caps like Apple).For most small and mid caps the only way to get a reasonable valuation is to sell the company, but that is an activity which is also in the doldrums. Dividends and buy backs can help but that requires profits and no nasties on the horizon
dealy
25/5/2023
08:33
According to media coverage this AM ,Liontrust is favouring Indivior given that a major new competitor has delayed the launch of a rival product , presumably to Indivior's former premier product, the declining Suboxone film. As a consequence, group revenue, presumably this year, will be better than previously expected. Not sure which rival to suboxone this is but a little checking will, no doubt, reveal the detail.
gregmorg
24/5/2023
08:59
Indivior to Commence Trading on Nasdaq Global Select Market in June
05/24/2023 | 04:17am BST


(MT Newswires) -- Indivior (INDV.L) said Tuesday it expects to start the trading of its ordinary shares on the Nasdaq Global Select Market on June 12 under the ticker INDV.

The pharmaceutical company will retain its premium listing on the London stock exchange and terminate its American depository receipt program, with the shares to be exchanged for Indivior shares on a 1:1 basis.

The US listing remains subject to the approval of the Securities and Exchange Commission.

Shares in Indivior were down more than 2% on Tuesday's close.

Price (GBP): £1470.00, Change: £-31.00, Percent Change: -2.07%

maywillow
24/5/2023
08:56
greg

are you saying that overall shares volumes are falling

I must admit i feel that there is little change but if you are right have those throwing in the towel have in main already sold and the other are holding on until
super good news prevails

As Always time will tell

maywillow
24/5/2023
08:42
Mm, it sounds as if everyone is throwing in the towel on equity investing. Now where within market cycles has that happened in the past! Must dig up my notes!
gregmorg
24/5/2023
05:47
Executives see the US as an environment that embraces higher growth, while they bemoan the lack of interest from UK-based investors in their home market, particularly pension funds that have increasingly shunned British stocks over the past two decades.

“There are no domestic equity investors here — everything else is a symptom,” said Michael Tory, founder of advisory firm Ondra Partners. “It’s not about the listing rules, the governance or the free float requirements. Global investors look to domestic investors for the signal to validate the investment, and that local signal has simply flickered out.”

steeplejack
23/5/2023
21:27
Google the decline in relation to pension funds and investment trusts. They still invest... but not in all the LSE has to offer
casholaa
23/5/2023
15:25
Nahhhh opvee needs to go live
casholaa
23/5/2023
08:04
This is great news. Surprised we’ve not seen a bigger impact today
youngers
23/5/2023
07:49
Cream of the crop.
casholaa
Chat Pages: Latest  180  179  178  177  176  175  174  173  172  171  170  169  Older

Your Recent History

Delayed Upgrade Clock